Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  10,498 results for "%22AUSTRALIA%22"

Your Filters

Subject : biomarkers Subject : blood pressure Subject : diabetes mellitus, type 2 Subject : glucose intolerance Subject : renal insufficiency, chronic Filter by : Author
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Prevalence of Insomnia (Symptoms) in T2D and Association With Metabolic Parameters and Glycemic Control: Meta-Analysis.

  • Authors : Koopman ADM; Amsterdam UMC, location VUmc, Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, HV Amsterdam, the Netherlands.; Beulens JW

Subjects: Insulin Resistance*; Biomarkers/Biomarkers/Biomarkers/*analysis ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*physiopathology

  • Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2020 Mar 01; Vol. 105 (3).Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Bone Turnover Markers in Men and Women with Impaired Fasting Glucose and Diabetes.

Subjects: Biomarkers/Biomarkers/Biomarkers/*blood ; Bone Remodeling/Bone Remodeling/Bone Remodeling/*physiology ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*blood

  • Source: Calcified tissue international [Calcif Tissue Int] 2019 Jun; Vol. 104 (6), pp. 599-604. Date of Electronic Publication: 2019 Jan 24.Publisher: Springer Verlag Country of Publication: United States NLM ID: 7905481 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Pooled analysis of Phase III trials indicate contrasting influences of renal function on blood pressure, body weight, and HbA1c reductions with empagliflozin.

  • Authors : Cherney DZI; Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada. Electronic address: .; Cooper ME

Subjects: Benzhydryl Compounds/Benzhydryl Compounds/Benzhydryl Compounds/*therapeutic use ; Blood Pressure/Blood Pressure/Blood Pressure/*drug effects ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Kidney international [Kidney Int] 2018 Jan; Vol. 93 (1), pp. 231-244. Date of Electronic Publication: 2017 Aug 30.Publisher: Elsevier Country of Publication: United States NLM ID: 0323470 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II.

  • Authors : Peters KE; Medical School, Faculty of Health and Medical Sciences, The University of Western Australia, Fremantle, Western Australia, Australia.; Proteomics International, Perth, Western Australia, Australia.

Subjects: Biomarkers/Biomarkers/Biomarkers/*blood ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*blood ; Renal Insufficiency, Chronic/Renal Insufficiency, Chronic/Renal Insufficiency, Chronic/*blood

  • Source: Diabetes care [Diabetes Care] 2017 Nov; Vol. 40 (11), pp. 1548-1555. Date of Electronic Publication: 2017 Aug 29.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Association between blood pressure variability and risk of kidney function decline in hypertensive patients without chronic kidney disease: a post hoc analysis of Systolic Blood Pressure Intervention Trial study.

  • Authors : Wang Z; Department of Cardiology, Anzhen Hospital.; Li W

Subjects: Hypertension*/Hypertension*/Hypertension*/physiopathology ; Hypertension*/Hypertension*/Hypertension*/complications ; Hypertension*/Hypertension*/Hypertension*/drug therapy

  • Source: Journal of hypertension [J Hypertens] 2024 Jul 01; Vol. 42 (7), pp. 1203-1211. Date of Electronic Publication: 2024 Mar 08.Publisher: Wolters Kluwer Health, Inc Country of Publication: Netherlands NLM ID: 8306882 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes.

  • Authors : Natale P; Sydney School of Public Health, The University of Sydney, Sydney, Australia.; Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/complications

  • Source: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2024 May 21; Vol. 5. Cochrane AN: CD015588. Date of Electronic Publication: 2024 May 21.Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-493X

Record details

Read More Add to Saved list
×
Academic Journal

Vascular endothelial growth factors and risk of cardio-renal events: Results from the CREDENCE trial.

  • Authors : Januzzi JL Jr; Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA; Heart Failure and Biomarker Trials, Baim Institute for Clinical Research, Boston, MA. Electronic address: .

Subjects: Biomarkers*/Biomarkers*/Biomarkers*/blood ; Canagliflozin*/Canagliflozin*/Canagliflozin*/therapeutic use ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/blood

  • Source: American heart journal [Am Heart J] 2024 May; Vol. 271, pp. 38-47. Date of Electronic Publication: 2024 Feb 22.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744

Record details

Read More Add to Saved list
×
Academic Journal

Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex.

  • Authors : Yu MK; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Vart P

Subjects: Glucosides*/Glucosides*/Glucosides*/therapeutic use ; Glucosides*/Glucosides*/Glucosides*/adverse effects ; Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/therapeutic use

  • Source: Journal of general internal medicine [J Gen Intern Med] 2024 May; Vol. 39 (6), pp. 921-930. Date of Electronic Publication: 2023 Dec 14.Publisher: Springer Country of Publication: United States NLM ID: 8605834 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank.

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/metabolism ; Diabetes Mellitus, Type 2* ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/complications

  • Source: Diabetologia [Diabetologia] 2024 May; Vol. 67 (5), pp. 837-849. Date of Electronic Publication: 2024 Feb 27.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Accelerated Risk-Based Implementation of Guideline-Directed Medical Therapy for Type 2 Diabetes and Chronic Kidney Disease.

  • Authors : Neuen BL; The George Institute for Global Health, University of New South Wales, Sydney, Australia (B.L.N.).; Department of Renal Medicine, Royal North Shore Hospital, Sydney, Australia (B.L.N.).

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology

  • Source: Circulation [Circulation] 2024 Apr 16; Vol. 149 (16), pp. 1238-1240. Date of Electronic Publication: 2024 Apr 15.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  10,498 results for "%22AUSTRALIA%22"